BIO Protocol, a pioneering platform in scientific research landscape, and NuDAO, a protocol in web3 technologies for life sciences, announced a new partnership.
A Transformative Partnership
In a recent press release, NuDAO revealed its strategic commitment to BIO Protocol with an allocation of 6.9% of its treasury. This move signifies a long-term collaboration aimed at accelerating the decentralized science ecosystem.
“This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science,” NuDAO said in a statement. “Through this allocation we’re strengthening the entire DeSci ecosystem.”
This collaboration brings together NuDAO’s expertise in decentralized biotech and AI technologies with BIO Protocol’s established DeSci infrastructure and expansive scientific network.
Key Elements of the Partnership
This partnership includes a deep scientific and technical collaboration:
-
Joint Development: NuDAO and BIO Protocol will collaborate on key scientific research initiatives, with a focus on IP and NFT development.
-
Co-Incubation Projects: Together, both organizations will incubate promising research projects, offering shared resources, expertise, and visibility.
-
Governance: Both entities will actively participate in each other’s governance frameworks, promoting a spirit of collaboration and shared decision-making in DeSci development.
Strengthening the DeSci Ecosystem
This partnership builds on each organization’s strengths:
NuDAO’s Expertise: Known for its work in decentralized biotech operations and AI technologies, NuDAO will contribute its deep knowledge of scientific IP management and research commercialization.
BIO Protocol’s Infrastructure: With a strong foundation in DeSci infrastructure and scientific networks, BIO Protocol brings a wealth of experience in blockchain-driven funding for biomedical research.
The Role of the CRISPR Token
A key component of this partnership is the integration of NuDAO’s CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research ecosystem and tools, further driving innovation.
Moreover, CRISPR token holders will have the opportunity to participate in pivotal decisions, influencing the future of decentralized science.
According to NuDAO, the collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking new opportunities for growth and innovation.
The ultimate goal is to create a global, decentralized community of researchers who can collaborate without borders. The long-term vision includes the commercialization of groundbreaking biotech innovations, ranging from rare diseases to longevity research.
The partnership also aligns with BIO Protocol’s recent investment from Binance Labs, a key player in the DeFi space. Worth noting, BIO Protocol reportedly raised over $64 million through a public sale, bringing its valuation to an impressive $219 million.
